<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03270163</url>
  </required_header>
  <id_info>
    <org_study_id>1708055</org_study_id>
    <secondary_id>2017-A00919-44</secondary_id>
    <nct_id>NCT03270163</nct_id>
  </id_info>
  <brief_title>Evaluation of Muscle Strength by Transcutaneous Electrical Stimulation</brief_title>
  <acronym>STRENGTH-ICU</acronym>
  <official_title>Evaluation of Muscle Strength by Transcutaneous Electrical Stimulation in Intensive Care Unit Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratoire de Physiologie de l'Exercice</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acquired Neuromyopathy of Resuscitation (NMAR) is a common condition. Its diagnosis is&#xD;
      difficult and often late because it is based on a clinical assessment of muscle strength (MRC&#xD;
      score) requiring the patient to be awake and cooperative.&#xD;
&#xD;
      Transcutaneous electrical stimulation consists of applying electrical stimulation along the&#xD;
      path of a motor nerve in order to generate contraction of the previously relaxed muscle. The&#xD;
      mechanical response thus generated is recorded and allows the muscular strength developed to&#xD;
      be assessed. Non-invasive and easily performed in the patient's bed, transcutaneous&#xD;
      electrical stimulation could be an interesting alternative for early assessment of muscle&#xD;
      strength in the still sedated resuscitation patient. However, this technique could be&#xD;
      perceived as uncomfortable or painful in the awake patient so that magnetic stimulation,&#xD;
      which is generally much better tolerated, should be preferred. However, magnetic stimulators&#xD;
      have a limited maximum magnetic field which may prevent supramaximal stimulation especially&#xD;
      in patients developing generalized edema (i.e., in the initial resuscitation phase).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose to conduct a reproducibility study of quadriceps force measurement in patients&#xD;
      undergoing resuscitation by transcutaneous electrical and/or magnetic neurostimulation in the&#xD;
      initial (i.e., &lt; 96 h) and late (&gt; 96 h) phases of resuscitation and then in the recovery&#xD;
      phase. For each investigative technique (i.e., electrical vs. magnetic), we will perform 2&#xD;
      types of stimulation: single stimulation and high frequency doublet stimulation (100 Hz),&#xD;
      repeated 3 times each.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 2</time_frame>
    <description>Reproductibility of the force measurement after electrical muscle stimulation by a doublet at 100 Hz.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 4</time_frame>
    <description>Reproductibility of the force measurement after electrical muscle stimulation by a doublet at 100 Hz.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>when the patient wakes up (on average 15 days)</time_frame>
    <description>Reproductibility of the force measurement after electrical muscle stimulation by a doublet at 100 Hz.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 2</time_frame>
    <description>Reproductibility of the force measurement after magnetic muscle stimulation by a doublet at 100 Hz.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 4</time_frame>
    <description>Reproductibility of the force measurement after magnetic muscle stimulation by a doublet at 100 Hz.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>when the patient wakes up (on average 15 days)</time_frame>
    <description>Reproductibility of the force measurement after magnetic muscle stimulation by a doublet at 100 Hz.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 2</time_frame>
    <description>Reproductibility of the force measurement after one simple electrical muscle stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 4</time_frame>
    <description>Reproductibility of the force measurement after one simple electrical muscle stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>when the patient wakes up (on average 15 days)</time_frame>
    <description>Reproductibility of the force measurement after one simple electrical muscle stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 2</time_frame>
    <description>Reproductibility of the force measurement after one simple magnetic muscle stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 4</time_frame>
    <description>Reproductibility of the force measurement after one simple magnetic muscle stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproductibility</measure>
    <time_frame>At day 6</time_frame>
    <description>Reproductibility of the force measurement after one simple magnetic muscle stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit acquired muscle weakness (ICUAW)</measure>
    <time_frame>1 month</time_frame>
    <description>Occurrence of ICUAW defined by a MRC score less than 48</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Magnetic and Transcutaneous electrical stimulation of quadriceps</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Transcutaneous electrical stimulation</intervention_name>
    <description>The following tests and measurements will be carried out on the patient within 3 days of inclusion and again between the 4th and 6th day after inclusion and upon awakening:&#xD;
three simple electrical stimulations,&#xD;
three electrical doublets at the frequency of 100Hz&#xD;
For each type of electrical stimulation, the stimulations will be carried out 3 times and reproduced at 1 hour intervals.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Magnetic stimulation</intervention_name>
    <description>The following tests and measurements will be carried out on the patient within 3 days of inclusion and again between the 4th and 6th day after inclusion and upon awakening:&#xD;
three simple magnetic stimulations,&#xD;
three magnetic doublets at the frequency of 100Hz&#xD;
For each type of magnetic stimulation, the stimulations will be carried out 3 times and reproduced at 1 hour intervals.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ultrasound measurement</intervention_name>
    <description>The ultrasound measurement of the thickness of the quadriceps muscle will be carried out on the patient within 3 days of inclusion and again between the 4th and 6th day after inclusion and upon awakening.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  admitted in intensive care unit B of ST-Etienne hospital&#xD;
&#xD;
          -  Predictable duration of mechanical ventilation of more than 72 hours&#xD;
&#xD;
          -  Patient whose family has given informed and written consent to the patient's&#xD;
             participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman,&#xD;
&#xD;
          -  Patients with peripheral nerve damage prior to or at the time of measurement&#xD;
&#xD;
          -  Curarized patients (non-efficacy of neurostimulation)&#xD;
&#xD;
          -  Fracture of limb or pelvis&#xD;
&#xD;
          -  Presence of a catheter in the stimulation zone (femoral artery or vein)&#xD;
&#xD;
          -  Patients suffering from psychiatric pathologies.&#xD;
&#xD;
          -  Brain pathology leading the patient to intensive care.&#xD;
&#xD;
          -  Patients with neuromuscular pathology.&#xD;
&#xD;
          -  Patients carrying equipment subject to possible electrical and/or magnetic&#xD;
             interference,&#xD;
&#xD;
          -  Patient with spinal fracture(s) at risk of spinal cord injury&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jérôme MOREL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jérôme MOREL, MD</last_name>
    <phone>0477828553</phone>
    <phone_ext>33</phone_ext>
    <email>jerome.morel@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Béatrice DEYGAS, CRA</last_name>
    <email>beatrice.deygas@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme MOREL, MD</last_name>
      <email>jerome.morel@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Jérôme MOREL</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laetitia BURNOL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Baptiste BOUCHET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive care unit acquired muscle weakness</keyword>
  <keyword>Transcutaneous electrical stimulation</keyword>
  <keyword>magnetic stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

